263 related articles for article (PubMed ID: 24732867)
1. Prucalopride improves bowel function and colonic transit time in patients with chronic constipation: an integrated analysis.
Emmanuel A; Cools M; Vandeplassche L; Kerstens R
Am J Gastroenterol; 2014 Jun; 109(6):887-94. PubMed ID: 24732867
[TBL] [Abstract][Full Text] [Related]
2. Association between health-related quality of life and symptoms in patients with chronic constipation: an integrated analysis of three phase 3 trials of prucalopride.
Tack J; Camilleri M; Dubois D; Vandeplassche L; Joseph A; Kerstens R
Neurogastroenterol Motil; 2015 Mar; 27(3):397-405. PubMed ID: 25581251
[TBL] [Abstract][Full Text] [Related]
3. Effect of prucalopride on symptoms of chronic constipation.
Tack J; Stanghellini V; Dubois D; Joseph A; Vandeplassche L; Kerstens R
Neurogastroenterol Motil; 2014 Jan; 26(1):21-7. PubMed ID: 24106924
[TBL] [Abstract][Full Text] [Related]
4. Effects of prucalopride on colonic transit, anorectal function and bowel habits in patients with chronic constipation.
Sloots CE; Poen AC; Kerstens R; Stevens M; De Pauw M; Van Oene JC; Meuwissen SG; Felt-Bersma RJ
Aliment Pharmacol Ther; 2002 Apr; 16(4):759-67. PubMed ID: 11929394
[TBL] [Abstract][Full Text] [Related]
5. Efficacy and Safety of Prucalopride in Chronic Constipation: An Integrated Analysis of Six Randomized, Controlled Clinical Trials.
Camilleri M; Piessevaux H; Yiannakou Y; Tack J; Kerstens R; Quigley EMM; Ke M; Da Silva S; Levine A
Dig Dis Sci; 2016 Aug; 61(8):2357-2372. PubMed ID: 27056037
[TBL] [Abstract][Full Text] [Related]
6. Prucalopride, a systemic enterokinetic, for the treatment of constipation.
Emmanuel AV; Roy AJ; Nicholls TJ; Kamm MA
Aliment Pharmacol Ther; 2002 Jul; 16(7):1347-56. PubMed ID: 12144586
[TBL] [Abstract][Full Text] [Related]
7. Prucalopride is effective in patients with severe chronic constipation in whom laxatives fail to provide adequate relief. Results of a double-blind, placebo-controlled clinical trial.
Coremans G; Kerstens R; De Pauw M; Stevens M
Digestion; 2003; 67(1-2):82-9. PubMed ID: 12743445
[TBL] [Abstract][Full Text] [Related]
8. Prucalopride succinate for the treatment of constipation: an update.
Bassotti G; Gambaccini D; Bellini M
Expert Rev Gastroenterol Hepatol; 2016; 10(3):291-300. PubMed ID: 26647167
[TBL] [Abstract][Full Text] [Related]
9. A randomized trial of 5-hydroxytryptamine4-receptor agonist, YKP10811, on colonic transit and bowel function in functional constipation.
Shin A; Acosta A; Camilleri M; Boldingh A; Burton D; Ryks M; Rhoten D; Zinsmeister AR
Clin Gastroenterol Hepatol; 2015 Apr; 13(4):701-8.e1. PubMed ID: 25148765
[TBL] [Abstract][Full Text] [Related]
10. A randomized, double-blind, placebo-controlled, phase 3 trial to evaluate the efficacy, safety, and tolerability of prucalopride in men with chronic constipation.
Yiannakou Y; Piessevaux H; Bouchoucha M; Schiefke I; Filip R; Gabalec L; Dina I; Stephenson D; Kerstens R; Etherson K; Levine A
Am J Gastroenterol; 2015 May; 110(5):741-8. PubMed ID: 25869393
[TBL] [Abstract][Full Text] [Related]
11. Use of prucalopride in adults with chronic idiopathic constipation.
Vijayvargiya P; Camilleri M
Expert Rev Clin Pharmacol; 2019 Jul; 12(7):579-589. PubMed ID: 31096799
[No Abstract] [Full Text] [Related]
12. Prucalopride induces high-amplitude propagating contractions in the colon of patients with chronic constipation: a randomized study.
Miner PB; Camilleri M; Burton D; Achenbach H; Wan H; Dragone J; Mellgard B
Neurogastroenterol Motil; 2016 Sep; 28(9):1341-8. PubMed ID: 27270968
[TBL] [Abstract][Full Text] [Related]
13. A placebo-controlled trial of prucalopride for severe chronic constipation.
Camilleri M; Kerstens R; Rykx A; Vandeplassche L
N Engl J Med; 2008 May; 358(22):2344-54. PubMed ID: 18509121
[TBL] [Abstract][Full Text] [Related]
14. Prucalopride: a review of its use in the management of chronic constipation.
Keating GM
Drugs; 2013 Nov; 73(17):1935-50. PubMed ID: 24194435
[TBL] [Abstract][Full Text] [Related]
15. Faecal retention: a common cause in functional bowel disorders, appendicitis and haemorrhoids--with medical and surgical therapy.
Raahave D
Dan Med J; 2015 Mar; 62(3):. PubMed ID: 25748875
[TBL] [Abstract][Full Text] [Related]
16. Prucalopride (Resolor) in the treatment of severe chronic constipation in patients dissatisfied with laxatives.
Tack J; van Outryve M; Beyens G; Kerstens R; Vandeplassche L
Gut; 2009 Mar; 58(3):357-65. PubMed ID: 18987031
[TBL] [Abstract][Full Text] [Related]
17. A randomized, double-blind, placebo-controlled trial to evaluate the efficacy, safety, and tolerability of long-term treatment with prucalopride.
Piessevaux H; Corazziari E; Rey E; Simren M; Wiechowska-Kozlowska A; Kerstens R; Cools M; Barrett K; Levine A
Neurogastroenterol Motil; 2015 Jun; 27(6):805-15. PubMed ID: 25808103
[TBL] [Abstract][Full Text] [Related]
18. Prucalopride for chronic constipation.
Lacy BE; Loew B; Crowell MD
Drugs Today (Barc); 2009 Dec; 45(12):843-53. PubMed ID: 20135019
[TBL] [Abstract][Full Text] [Related]
19. Efficacy and tolerability of prucalopride in patients with constipation due to spinal cord injury.
Krogh K; Jensen MB; Gandrup P; Laurberg S; Nilsson J; Kerstens R; De Pauw M
Scand J Gastroenterol; 2002 Apr; 37(4):431-6. PubMed ID: 11989834
[TBL] [Abstract][Full Text] [Related]
20. Prucalopride.
Frampton JE
Drugs; 2009; 69(17):2463-76. PubMed ID: 19911858
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
